Qiagen NV (LTS:0RLT)
€ 43.54 0 (0%) Market Cap: 9.70 Bil Enterprise Value: 10.12 Bil PE Ratio: 113.19 PB Ratio: 2.90 GF Score: 82/100

Qiagen NV Annual Shareholders Meeting Transcript

Jun 30, 2020 / 01:00PM GMT
Release Date Price: €39.58 (-0.67%)
Sven BjÃ;rklund;Independent Supervisory Board Chairman

¶; -

So ladies and gentlemen, my name is Håkan Björklund. I'm the Chairman of the Supervisory Board of QIAGEN N.V., and I would like to welcome you all to this truly unusual Annual General Meeting of the Shareholders from QIAGEN. This is a very important and historic event for QIAGEN given that we also have various agenda items related to the proposed acquisition of QIAGEN by Thermo Fisher Scientific. This meeting is not to make a final decision on that transaction since it's up to each individual shareholders to decide whether to accept the offer or not. This meeting provides an opportunity to discuss the offer and provide you with relevant information as you make a decision.

It is unfortunate that we could not meet in person and provide you physical access to this meeting due to the global outbreak of COVID-19. At the same time, I'm pleased that many of you are able to participate via the webcast. This solution is in the best interest of protecting the health and safety of you as well as our team involved in this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot